Loading clinical trials...
Loading clinical trials...
Long-term Safety and Efficacy Study of Deferiprone in Patients With Pantothenate Kinase-Associated Neurodegeneration (PKAN)
Conditions
Interventions
Deferiprone oral solution
Locations
4
United States
UCSF Benioff Children's Hospital Oakland
Oakland, California, United States
Klinikum der Universität München
Munich, Germany
Foundation Neurological Institute C. Besta
Milan, Italy
Newcastle University Institute of Human Genetics
Newcastle upon Tyne, United Kingdom
Start Date
June 1, 2014
Primary Completion Date
March 16, 2018
Completion Date
March 16, 2018
Last Updated
August 25, 2020
Lead Sponsor
ApoPharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions